Shai Novik, Executive Chairman of the Board at Enlivex Therapeutics, Ltd. (NASDAQ:ENLV), was a guest speaker at Benzinga’s All Access on June 17th, 2022.
Enlivex Therapeutics is a clinical stage, macrophage reprogramming immunotherapy company developing Allocetra - an off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
Watch full interview here
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
